Merz Pharma GmbH & Co. KgaA - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Business description – A detailed description of the company’s operations and business divisions.
Corporate strategy – GlobalData’s summarization of the company’s business strategy.
SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history – Progression of key events associated with the company.
Major products and services – A list of major products, services and brands of the company.
Key competitors – A list of key competitors to the company.
Key employees – A list of the key executives of the company.
Executive biographies – A brief summary of the executives’ employment history.
Key operational heads – A list of personnel heading key departments/functions.
Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Key manufacturing facilities – A list of key manufacturing facilities of the company.
Merz Pharma GmbH & Co. KgaA (Merz Pharma) is a pharmaceutical company. It focuses on the development of products for aesthetic and medical dermatology and neurological movement disorders. The company offers products for Alzheimer’s disease, depression, dystonia, hair loss, liver diseases, Parkinson’s disease, cold, scars, wrinkles and other skin disorders. It also offers vitamins and minerals, and hygienic products for medical disinfection and cleaning. Merz Pharma markets products under various brands such as Merz Spezial, Tetesept, Merz Spezial Dragees and Microbions, among others. It offers dental products through its subsidiary, Merz Dental. The company has operations in Australia, Switzerland, Spain, France, the US and the UK, among others. Merz Pharma is headquartered in Frankfurt, Hessen, Germany.
The company intends to expand its operations through acquisitions. In line with this strategy, Merz Pharma acquired Ulthera, Inc., which could strengthen its position in aesthetics market.
Reasons to Buy
Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.